Confo Therapeutics
The computed 12-month bankruptcy probability of Confo Therapeutics is 0.3% (very low). The company has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 11 yrs |
| Board | 23 |
| Locations | 1 |
| Publications | 100 |
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | volledig | 08-06-2026 | 2026-00144378 |
| 31-12-2024 | volledig | 12-06-2025 | 2025-00136739 |
| 31-12-2023 | volledig | 17-07-2024 | 2024-00263726 |
| 31-12-2022 | volledig | 05-06-2023 | 2023-00116898 |
| 31-12-2021 | verkort | 04-07-2022 | 2022-20166481 |
| 31-12-2020 | verkort | 23-06-2021 | 2021-24100430 |
| 31-12-2019 | verkort | 15-06-2020 | 2020-17700426 |
| 31-12-2018 | verkort | 13-06-2019 | 2019-19400468 |
| 31-12-2017 | verkort | 19-06-2018 | 2018-21300121 |
| 31-12-2016 | verkort | 08-06-2017 | 2017-16800294 |
-
Current31-07-2024 → present
-
CVBioConsulting BVLegal entityManaging director· perm. rep.: Cedric VerverkenState Gazette act 24088114 (11-06-2024)Current11-06-2024 → present
-
Current25-08-2023 → present
2 events
- 05-06-2025 Mandate renewed· Director
- 25-08-2023 Appointed· Director
-
Capricorn Partners NVLegal entityDirector· perm. rep.: Jos PeetersState Gazette act 22100097 (22-08-2022)Current30-06-2022 → present
-
Participatiemaatschappij Vlaanderen NVLegal entityDirector· perm. rep.: Filip GoossensState Gazette act 22100097 (22-08-2022)Current30-06-2022 → present
-
Current30-06-2022 → present
2 events
- 05-06-2025 Mandate renewed· Director
- 30-06-2022 Mandate renewed· Director
-
Current31-05-2022 → present
5 events
- 31-07-2024 Appointed· Director
- 25-08-2023 Resigned· Director
- 25-08-2023 Appointed· Director
- 30-06-2022 Mandate renewed· Director
- 31-05-2022 Appointed· Director
-
Current01-10-2021 → present
-
Current13-11-2020 → present
-
Current29-06-2020 → present
-
Current02-07-2019 → present
2 events
- 30-06-2022 Mandate renewed· Director
- 02-07-2019 Mandate renewed· Director
-
Capricorn Venture PartnersLegal entityDirector· perm. rep.: Katya SmirnyaginaState Gazette act 19070314 (24-05-2019)Current29-04-2019 → present
-
PARTICIPATIEMAATSCHAPPIJ VLAANDERENLegal entityDirector· perm. rep.: Chris De JongheState Gazette act 19070314 (24-05-2019)Current29-04-2019 → present
-
Current29-04-2019 → present
5 events
- 31-07-2024 Appointed· Director
- 25-08-2023 Resigned· Director
- 25-08-2023 Appointed· Director
- 30-06-2022 Mandate renewed· Director
- 29-04-2019 Appointed· Director
-
Wellington Partners Life Sciences V GmbH & Co. KGLegal entityDirector· perm. rep.: Karl NäglerState Gazette act 24420026 (31-07-2024)Current29-04-2019 → present
7 events
- 31-07-2024 Appointed· Director
- 08-03-2024 Resigned· Director
- 08-03-2024 Appointed· Director
- 25-08-2023 Resigned· Director
- 25-08-2023 Appointed· Director
- 30-06-2022 Mandate renewed· Director
- 29-04-2019 Appointed· Director
-
Current15-02-2019 → present
-
Current01-07-2018 → present
-
Current02-01-2017 → present
-
CVBIOCONSULTING BVBALegal entityManaging director· perm. rep.: Cedric VerverkenState Gazette act 16142231 (14-10-2016)Current01-10-2016 → present
-
Current08-09-2016 → present
6 events
- 31-07-2024 Appointed· Director
- 30-06-2022 Mandate renewed· Director
- 05-08-2021 Mandate renewed· Director
- 29-04-2019 Appointed· Managing director
- 02-01-2017 Mandate renewed· Director
- 08-09-2016 Appointed· Director
-
V-Bio Fund 1Legal entityDirector· perm. rep.: DE JONGHE ChrisState Gazette act 16008823 (18-01-2016)Current18-01-2016 → present
-
Current18-01-2016 → present
-
TOULONLegal entityManaging director· perm. rep.: Stéphane Van RooijenState Gazette act 15117191 (13-08-2015)Current18-06-2015 → present
Former directors (6)
-
CAPRICORN PARTNERSLegal entityDirector· perm. rep.: Jos PeetersState Gazette act 23133622 (19-10-2023)Former— → 25-08-2023
2 events
- 25-08-2023 Resigned· Director
- 01-10-2021 Resigned· Director
-
Former18-01-2016 → 25-08-2023
4 events
- 25-08-2023 Resigned· Director
- 30-06-2022 Mandate renewed· Director
- 29-04-2019 Appointed· Director
- 18-01-2016 Appointed· Director
-
Participatiemaatschappij VlaanderenLegal entityDirector· perm. rep.: Filip GoossensState Gazette act 23133622 (19-10-2023)Former22-12-2017 → 25-08-2023
5 events
- 25-08-2023 Resigned· Director
- 25-08-2023 Appointed· Director
- 13-11-2020 Resigned· Director
- 19-03-2020 Mandate renewed· Director
- 22-12-2017 Appointed· Director
-
Former29-04-2019 → 30-04-2022
2 events
- 30-04-2022 Resigned· Director
- 29-04-2019 Appointed· Director
-
Former— → 30-06-2018
-
Former— → 02-01-2017
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| BDO BedrijfsrevisorenCurrent Statutory auditor · represented by Veerle Catry |
— | 29-09-2015 → present |
| BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISESCurrent Statutory auditor · represented by Veerle Catry |
— | 30-06-2022 → present |
| Deloitte Bedrijfsrevisoren/Réviseurs d’EntreprisesCurrent Company auditor · represented by Pieter-Jan Van Durme |
A02436 | 09-07-2025 → present |
| KPMG Audit BVBACurrent Statutory auditor · represented by Kris Clerckx |
— | 07-02-2024 → present |
| NACE primary | 72109 |
| Legal form | Public limited company(014) |
| Incorporation | 11-06-2015 |
| Status | Active |
| Postal code | 9052 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44082B0087/00E000 | Flanders | 9,447 m² | 1 · 2,132 m² | 21.5 m · 5 fl. |
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
04-03-2026 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "CONFO THERAPEUTICS, AFGEKORT : CONFO",
"legal_form": "NV"
}
}04-03-2026 3 directors appointed
- CVBioConsulting BV — Dagelijks bestuur
- Aquilexis BV — Dagelijks bestuur
- CVBioConsulting BV — Dagelijks bestuur
Technical details
{
"events": [
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": null,
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": null,
"name": "CVBioConsulting BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": "2024-07-18",
"evidence_quote": "De raad van bestuur bevestigt en bekrachtigt de delegatie van bevoegdheden aan CVBioConsulting BV (vast vertegenwoordigd door Cedric Ververken), als Chief Executive Officer (CEO), belast met het dagelijks bestuur van de Vennootschap, zoals beslist op 30 september 2016 en bekendgemaakt in de Bijlagen",
"decharge_status": null,
"mandate_duration": {
"kind": "until_date",
"value": "2024-07-18"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": null,
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": "0715.587.212",
"name": "Aquilexis BV",
"address": "Goudbrokaatstraat 2, 9030 Gent",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": "2026-01-01",
"evidence_quote": "Aquilexis BV (met zetel te Goudbrokaatstraat 2, 9030 Gent, ingeschreven in het rechtspersonenregister met ondernemingsnummer 0715.587.212, gekend op de ondernemingsrechtbank te Gent, afdeling Gent) met als vaste vertegenwoordiger Mr. Frank Landolt ([...]) als Chief Counsel Intellectual Property;",
"decharge_status": null,
"mandate_duration": {
"kind": "until_date",
"value": "2026-01-01"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": null,
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": "0663.551.462",
"name": "CVBioConsulting BV",
"address": "Zwijnaardsesteenweg 79, 9820 Merelbeke-Melle",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": "2026-01-01",
"evidence_quote": "CVBioConsulting BV (met zetel te Zwijnaardsesteenweg 79, 9820 Merelbeke-Melle, ingeschreven in het rechtspersonenregister met ondernemingsnummer 0663.551.462, gekend op de ondernemingsrechtbank te Gent, afdeling Gent) met als vaste vertegenwoordiger Mr. Cedric Ververken ([...]) als Chief Executive O",
"decharge_status": null,
"mandate_duration": {
"kind": "until_date",
"value": "2026-01-01"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2026-03-04",
"filing_date": "2026-02-24",
"act_kind_objet": "DELEGATIE VAN BEVOEGDHEDEN"
},
"decisions": [
{
"body": "raad_van_bestuur",
"date": "2026-02-13",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0632.474.939",
"name_full": "CONFO THERAPEUTICS",
"legal_form": "NAAMLOZE VENNOOTSCHAP"
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}04-03-2026 5 directors appointed
- Cedric Ververken — Chief executive officer (ceo)
- Stephen Dowd — Chief business officer (cbo)
- Frank Landolt — Chief counsel intellectual property
- Paolo Vicini — Chief development officer (cdo)
- Christel Menet — Chief scientific officer (cso)
Technical details
{
"events": [
{
"kind": "director_in",
"role": "Chief Executive Officer (CEO)",
"person": {
"rrn": null,
"name": "Cedric Ververken",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Chief Business Officer (CBO)",
"person": {
"rrn": null,
"name": "Stephen Dowd",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Chief Counsel Intellectual Property",
"person": {
"rrn": null,
"name": "Frank Landolt",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Chief Development Officer (CDO)",
"person": {
"rrn": null,
"name": "Paolo Vicini",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Chief Scientific Officer (CSO)",
"person": {
"rrn": null,
"name": "Christel Menet",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "CONFO THERAPEUTICS"
}
}26-01-2026 Articles of association amended — translation of the articles and coordination of the articles
Technical details
{
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2026-01-26",
"filing_date": "2026-01-22",
"act_kind_objet": "STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN)"
},
"decision": {
"body": "bijzondere_algemene_vergadering",
"act_date": "2025-12-31",
"unanimous": null
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"other"
],
"scope": null,
"trigger": null,
"language_after": null,
"language_before": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0632.474.939",
"name_full_after": "Confo Therapeutics",
"legal_form_after": "Naamloze vennootschap",
"name_full_before": "Confo Therapeutics",
"current_zetel_raw": "Technologiepark-Zwijnaarde 30, 9052 Gent",
"legal_form_before": "Naamloze vennootschap"
},
"special_mandates": [
{
"holder_kbo": "0632.474.939",
"holder_name": "Confo Therapeutics",
"scope_categories": [
"kbo"
],
"with_substitution": true
}
],
"articles_modified": [
{
"summary": "Het aantal Winstbewijzen uitgegeven onder de opschortende voorwaarde van de uitoefening van inschrijvingsrechten bedraagt 2.256.958. Op 31 december 2025 bedraagt het aantal effectief door de Vennootschap uitgegeven Winstbewijzen 29.333.",
"new_text": "15.1 Het aantal Winstbewijzen uitgegeven onder de opschortende voorwaarde van de uitoefening van inschrijvingsrechten bedraagt 2.256.958 (de \u201CWinstbewijzen). Op 31 december 2025 bedraagt het aantal effectief door de Vennootschap uitgegeven Winstbewijzen 29.333.",
"change_kind": "replaced",
"article_title": null,
"article_number": "15.1"
}
],
"governance_change": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim CARNEWAL",
"org_rep_person_name": null
},
"co_filed_documents": [
"een uitgifte van de akte",
"de geco\u00F6rdineerde tekst van statuten"
],
"shareholder_rights": null,
"voorwerp_change_summary": null,
"capital_structure_change": {
"operations": [
"share_class_creation"
],
"split_ratio": null,
"shares_after": null,
"shares_before": null,
"capital_after_eur": null,
"capital_before_eur": null,
"share_classes_after": [
{
"count": 29333,
"label": "Winstbewijzen",
"rights_summary": "Recht op 1 Winstbewijs per inschrijvingsrecht.",
"voting_per_share": null
}
]
},
"coordinated_text_lineage": null
}26-01-2026 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "Confo Therapeutics"
},
"legal_form_change": {
"new": "",
"old": "Naamloze vennootschap",
"changed": false
}
}26-11-2025 Articles of association amended — translation of the articles and coordination of the articles
Technical details
{
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2025-11-26",
"filing_date": "2025-11-24",
"act_kind_objet": "STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN)"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-11-13",
"unanimous": null
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"other"
],
"scope": null,
"trigger": null,
"language_after": null,
"language_before": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0632.474.939",
"name_full_after": "Confo Therapeutics",
"legal_form_after": "Naamloze vennootschap",
"name_full_before": "Confo Therapeutics",
"current_zetel_raw": "Technologiepark-Zwijnaarde 30, 9052 Gent",
"legal_form_before": "Naamloze vennootschap"
},
"special_mandates": [
{
"holder_kbo": null,
"holder_name": "meester VANHULLE Florence",
"scope_categories": [
"kbo"
],
"with_substitution": true
},
{
"holder_kbo": null,
"holder_name": "NautaDutilth",
"scope_categories": [
"kbo"
],
"with_substitution": true
}
],
"articles_modified": [
{
"summary": "Artikel 15 wordt gewijzigd om de vernietiging van niet-toegekende ESOP rechten, de uitgifte van ESOP 2025 rechten en de rechten van Winstbewijzen in overeenstemming te brengen met de genomen beslissingen.",
"new_text": "ARTIKEL 15. Winstbewijzen\n15.1 Het aantal Winstbewijzen uitgegeven onder de opschortende voorwaarde van de uitoefening van inschrijvingsrechten bedraagt 2.256.958. Op [datum van de BAV], bedraagt het aantal effectief door de Vennootschap uitgegeven Winstbewijzen 26.583.\n15.2 Indien de uitoefenprijs van de inschrijvingsrechten die recht geven op de Winstbewijzen hoger is dan de fractiewaarde van de",
"change_kind": "amended",
"article_title": "Winstbewijzen",
"article_number": "15"
}
],
"governance_change": {
"organ_kind_after": null,
"organ_kind_before": null,
"admin_delegated_added": [
{
"name": "meester VANHULLE Florence",
"excluded_powers": []
},
{
"name": "NautaDutilth",
"excluded_powers": []
}
],
"representation_rule_after": null,
"co_signature_threshold_eur": null,
"representation_rule_before": null
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim CARNEWAL",
"org_rep_person_name": null
},
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"het verslag van de raad van bestuur",
"de verslagen van de commissaris",
"het inschrijvingsrechtenplan",
"een aanwezigheidslijst",
"de geco\u00F6rdineerde tekst van statuten"
],
"shareholder_rights": {
"quorum_rules_changed": false,
"liquidation_preference_text": null,
"voorkeurrecht_rules_changed": true,
"aandelenoverdracht_restrictions_changed": true
},
"voorwerp_change_summary": "Vernietiging van 210.153 niet-toegekende ESOP inschrijvingsrechten en overeenkomstige vermindering van de maximum aantallen winstbewijzen. Uitgifte van 435.245 nieuwe ESOP 2025 inschrijvingsrechten. Wijziging van artikel 15 van de statuten om deze beslissingen in te brengen.",
"capital_structure_change": {
"operations": [
"share_cancellation",
"share_class_creation"
],
"split_ratio": null,
"shares_after": null,
"shares_before": null,
"capital_after_eur": null,
"capital_before_eur": null,
"share_classes_after": [
{
"count": 2256958,
"label": "Winstbewijzen",
"rights_summary": "Geen stemrecht, behoudens uitzonderlijke wetgeving. Beschikken over rechten en voordelen gelijk aan Gewone Aandelen.",
"voting_per_share": 0.0
},
{
"count": null,
"label": "Gewone Aandelen",
"rights_summary": "Stemrecht en rechten in winst en liquidatiesaldo.",
"voting_per_share": 1.0
}
]
},
"coordinated_text_lineage": null
}26-11-2025 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "Confo Therapeutics"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}26-11-2025 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2025-11-13",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0632.474.939",
"name_full": "CONFO THERAPEUTICS, AFGEKORT : CONFO",
"legal_form": "NV"
},
"signature_regime": null,
"special_mandates": [
{
"quote": "De vergadering verleent bijzondere volmacht aan iedere bestuurder van de Vennootschap, meester VANHULLE Florence en iedere andere advocaat of medewerker van het kantoor \u201CNautaDutilth\u201D, allen daartoe woonstkeuze gedaan hebbende te 1000 Brussel, Terhulpsesteenweg 120, evenals aan hun bedienden, aangestelden en lasthebbers, allen individueel bevoegd, met mogelijkheid tot indeplaatsstelling, teneinde het register van inschrijvingsrechten bij te werken.",
"holder_kbo": null,
"holder_name": "NautaDutilth",
"scope_categories": [
"register_update",
"filing_formalities",
"publication",
"KBO"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}28-07-2025 3 directors appointed
- Dieter Weinand — Onafhankelijke bestuurder
- Robert Scott — Onafhankelijke bestuurder
- Pieter-Jan Van Durme — Commissaris
Technical details
{
"events": [
{
"kind": "director_in",
"role": "Onafhankelijke Bestuurder",
"person": {
"rrn": null,
"name": "Dieter Weinand",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Onafhankelijke Bestuurder",
"person": {
"rrn": null,
"name": "Robert Scott",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Pieter-Jan Van Durme",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "Confo Therapeutics"
}
}28-07-2025 1 director appointed, 2 reappointed
- Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises — Commissaris
- Dieter Weinand — Bestuurder
- Robert Scott — Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dieter Weinand",
"address": "236 Cascade Lane, Palm Beach Shores, Florida 33404 (Verenigde Staten)",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": "2025-06-05",
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2027"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Robert Scott",
"address": "32076 Canterhill Place, Westlake Village CA 91361 (Verenigde Staten)",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": "2025-06-05",
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2027"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0429.053.863",
"name": "Deloitte Bedrijfsrevisoren/R\u00E9viseurs d\u0027Entreprises",
"address": "Luchthaven Brussel Nationaal 1J, 1930 Zaventem, Belgi\u00EB",
"country": "BE",
"legal_form": "besloten vennootschap"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": 3
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2025-07-28",
"filing_date": "2025-07-24",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2025-07-09",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0632.474.939",
"name_full": "Confo Therapeutics",
"legal_form": "Naamloze vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim CARNEWAL",
"org_rep_person_name": null,
"person_role_at_subject": "notaris"
},
"co_filed_documents": [
"een uitgifte van de akte",
"\u00E9\u00E9n volmacht",
"de geco\u00F6rdineerde tekst van statuten",
"de schriftelijke besluiten van de aandeelhouders"
],
"corrected_publication_numac": null
}28-07-2025 Articles of association amended — translation of the articles and coordination of the articles
Technical details
{
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2025-07-28",
"filing_date": "2025-07-24",
"act_kind_objet": "STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN), ONTSLAGEN, BENOEMINGEN"
},
"decision": {
"body": "enig_aandeelhouder_schriftelijk",
"act_date": "2025-07-09",
"unanimous": true
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"other"
],
"scope": null,
"trigger": "wvv_adaptation",
"language_after": null,
"language_before": null
},
"bedrijfsrevisor": {
"firm_kbo": "0429.053.863",
"firm_name": "Deloitte Bedrijfsrevisoren/R\u00E9viseurs d\u0027Entreprises",
"ibr_number": "A02436",
"individual_name": "Pieter-Jan Van Durme"
},
"subject_company": {
"kbo": "0632.474.939",
"name_full_after": "Confo Therapeutics",
"legal_form_after": "Naamloze vennootschap",
"name_full_before": "Confo Therapeutics",
"current_zetel_raw": "Technologiepark-Zwijnaarde 30, 9052 Gent",
"legal_form_before": "Naamloze vennootschap"
},
"special_mandates": [
{
"holder_kbo": null,
"holder_name": "CVBioConsulting BV",
"scope_categories": [
"kbo"
],
"with_substitution": true
}
],
"articles_modified": [
{
"summary": "Artikel 15.1 wordt vervangen door een nieuwe tekst die het aantal Winstbewijzen onder opschortende voorwaarde van inschrijvingsrechten vastlegt.",
"new_text": "15.1 Het aantal Winstbewijzen uitgegeven onder de opschortende voorwaarde van de uitoefening van inschrijvingsrechten bedraagt 2.256.958 (de \u201CWinstbewijzen\u201D), waarvan er op 9 juli 2025 reeds 26.583 Winstbewijzen effectief werden uitgegeven door de Vennootschap ingevolge de vaststelling van uitoefeningen van inschrijvingsrechten.",
"change_kind": "replaced",
"article_title": null,
"article_number": "15.1"
}
],
"governance_change": {
"organ_kind_after": null,
"organ_kind_before": null,
"admin_delegated_added": [
{
"name": "CVBioConsulting BV",
"excluded_powers": []
}
],
"representation_rule_after": null,
"co_signature_threshold_eur": null,
"representation_rule_before": null
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim CARNEWAL",
"org_rep_person_name": null
},
"co_filed_documents": [
"een uitgifte van de akte",
"\u00E9\u00E9n volmacht",
"de geco\u00F6rdineerde tekst van statuten",
"de schriftelijke besluiten van de aandeelhouders"
],
"shareholder_rights": null,
"voorwerp_change_summary": null,
"capital_structure_change": null,
"coordinated_text_lineage": null
}28-07-2025 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2025-07-09",
"legal_form_change": false
},
"bedrijfsrevisor": {
"quote": "De Aandeelhouders beslissen tot benoeming van de besloten vennootschap \u0022Deloitte Bedrijfsrevisoren/R\u00E9viseurs d\u0027Entreprises\u0022 met zetel te Luchthaven Brussel Nationaal 1J, 1930 Zaventem, Belgi\u00EB, ingeschreven in de Kruispuntbank van Ondernemingen onder het nummer 0429.053.863 (RPR Brussel, Nederlandstalige afdeling), vertegenwoordigd door haar vaste vertegenwoordiger de heer Pieter-Jan Van Durme, bedrijfsrevisor met registratienummer A02436, als commissaris van de vennootschap",
"firm_kbo": "0429.053.863",
"firm_name": "Deloitte Bedrijfsrevisoren/R\u00E9viseurs d\u0027Entreprises",
"ibr_number": "A02436",
"individual_name": "Pieter-Jan Van Durme"
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "CONFO THERAPEUTICS, AFGEKORT : CONFO",
"legal_form": "NV"
},
"signature_regime": "joint_two",
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}28-07-2025 1 director appointed, 2 reappointed
- Pieter-Jan Van Durme — Commissaris
- Dieter Weinand — Bestuurder
- Robert Scott — Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dieter Weinand",
"address": null,
"birth_date": null
},
"effective_date": "2025-06-05",
"evidence_quote": "De Aandeelhouders besluiten om, met ingang van 5 juni 2025 de volgende personen te herbenoemen als Onafhankelijke Bestuurder ... Dieter Weinand, wonende te 236 Cascade Lane, Palm Beach Shores, Florida 33404 (Verenigde Staten)"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Robert Scott",
"address": null,
"birth_date": null
},
"effective_date": "2025-06-05",
"evidence_quote": "De Aandeelhouders besluiten om, met ingang van 5 juni 2025 de volgende personen te herbenoemen als Onafhankelijke Bestuurder ... Robert Scott, wonende te 32076 Canterhill Place, Westlake Village CA 91361 (Verenigde Staten)."
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Pieter-Jan Van Durme",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0429053863",
"name": "Deloitte Bedrijfsrevisoren/R\u00E9viseurs d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De Aandeelhouders beslissen tot benoeming van de besloten vennootschap \u0022Deloitte Bedrijfsrevisoren/R\u00E9viseurs d\u0027Entreprises\u0022 met zetel te Luchthaven Brussel Nationaal 1J, 1930 Zaventem, Belgi\u00EB, ingeschreven in de Kruispuntbank van Ondernemingen onder het nummer 0429.053.863 (RPR Brussel, Nederlandsta"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "CONFO THERAPEUTICS, AFGEKORT : CONFO",
"legal_form": "NV"
}
}28-07-2025 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "Confo Therapeutics"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}16-01-2025 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "Confo Therapeutics"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}16-01-2025 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2024-12-24",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0632.474.939",
"name_full": "CONFO THERAPEUTICS, AFGEKORT : CONFO",
"legal_form": "NV"
},
"signature_regime": null,
"special_mandates": [
{
"quote": "De vergadering verleent bijzondere volmacht aan iedere bestuurder van de Vennootschap, meester VANDEPITTE Louisa, meester DE BRAUWER Lauren en iedere andere advocaat of medewerker van het kantoor \u201CNautaDutilth\u201D, allen daartoe woonstkeuze gedaan hebbende te 1000 Brussel, Terhulpsesteenweg 120, evenals aan hun bedienden, aangestelden en lasthebbers, allen individueel bevoegd, met mogelijkheid tot indeplaatsstelling, teneinde alle noodzakelijke of nuttige formaliteiten te kunnen vervullen met betrekking tot de bovenstaande beslissingen van de vergadering, met inbegrip van het ondertekenen en neerleggen van de aanvraag tot wijziging van de inschrijving van de Vennootschap bij de diensten van de Kruispuntbank van Ondernemingen, het neerleggen van alle stukken bij de bevoegde griffie en overgaan tot de nodige formaliteiten voor de bekendmaking van de beslissingen van de Vennootschap in de Bijlagen bij het Belgisch Staatsblad.",
"holder_kbo": null,
"holder_name": "NautaDutilth",
"scope_categories": [
"filing",
"publication",
"KBO"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}16-01-2025 Articles of association amended — translation of the articles, coordination of the articles and amendment of specific articles
Technical details
{
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2025-01-16",
"filing_date": "2025-01-14",
"act_kind_objet": "STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN)"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-12-24",
"unanimous": null
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"targeted_amendment"
],
"scope": null,
"trigger": null,
"language_after": null,
"language_before": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0632.474.939",
"name_full_after": "Confo Therapeutics",
"legal_form_after": "Naamloze vennootschap",
"name_full_before": "Confo Therapeutics",
"current_zetel_raw": "Technologiepark-Zwijnaarde 30, 9052 Gent",
"legal_form_before": "Naamloze vennootschap"
},
"special_mandates": [
{
"holder_kbo": null,
"holder_name": "NautaDutilth",
"scope_categories": [
"kbo",
"ubo",
"btw",
"estox",
"publication"
],
"with_substitution": true
}
],
"articles_modified": [
{
"summary": "Artikel 15 is gewijzigd om de vernietiging van Niet-toegekende ESOP Inschrijvingsrechten en de uitgifte van ESOP 2024 Inschrijvingsrechten in overeenstemming te brengen. Het artikel definieert het aantal Winstbewijzen, de uitgiftepremies, de terugbetalingvoorwaarden en de rechten van Winstbewijzen, ",
"new_text": "ARTIKEL 15. Winstbewijzen\n15.1 Het aantal Winstbewijzen uitgegeven onder de opschortende voorwaarde van de uitoefening van inschrijvingsrechten bedraagt 2.256.958. Op 24 december 2024, bedraagt het aantal effectief door de Vennootschap uitgegeven Winstbewijzen 11.213.\n15.2 Indien de uitoefenprijs van de inschrijvingsrechten die recht geven op de Winstbewijzen hoger is dan de fractiewaarde van de a",
"change_kind": "amended",
"article_title": "Winstbewijzen",
"article_number": "15"
}
],
"governance_change": {
"organ_kind_after": null,
"organ_kind_before": null,
"admin_delegated_added": [
{
"name": "Louisa VANDEPITTE",
"excluded_powers": []
},
{
"name": "Lauren DE BRAUWER",
"excluded_powers": []
}
],
"representation_rule_after": null,
"co_signature_threshold_eur": null,
"representation_rule_before": null
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim CARNEWAL",
"org_rep_person_name": null
},
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"een aanwezigheidslijst",
"de geco\u00F6rdineerde tekst van statuten",
"het verslag van de raad van bestuur",
"het verslag (of de verslagen) van de commissaris opgesteld in toepassing van artikelen 7:155 en 7:180 van het Wetboek van vennootschappen en verenigingen"
],
"shareholder_rights": {
"quorum_rules_changed": false,
"liquidation_preference_text": null,
"voorkeurrecht_rules_changed": true,
"aandelenoverdracht_restrictions_changed": true
},
"voorwerp_change_summary": null,
"capital_structure_change": {
"operations": [
"share_class_creation",
"share_cancellation",
"capital_increase_kind",
"wvv_capital_release"
],
"split_ratio": null,
"shares_after": null,
"shares_before": null,
"capital_after_eur": null,
"capital_before_eur": null,
"share_classes_after": [
{
"count": 2256958,
"label": "Winstbewijzen",
"rights_summary": "Geen stemrecht, behoudens in uitzonderlijke omstandigheden. Behandeld als Gewone Aandelen voor berekening van winst en liquidatiesaldo.",
"voting_per_share": 0.0
},
{
"count": 11213,
"label": "Gewone Aandelen",
"rights_summary": "Beschikken over stemrecht.",
"voting_per_share": 1.0
}
]
},
"coordinated_text_lineage": null
}31-07-2024 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": true
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "Confo Therapeutics"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}31-07-2024 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": true,
"effective_date": "2024-07-18",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0632.474.939",
"name_full": "CONFO THERAPEUTICS, AFGEKORT : CONFO",
"legal_form": "NV"
},
"signature_regime": "joint_two",
"special_mandates": [
{
"quote": "De vergadering verleent bijzondere volmacht aan iedere bestuurder van de Vennootschap, meester VANDEPITTE Louisa, meester DE BRAUWER Lauren en iedere andere advocaat of medewerker van het kantoor \u201CNautaDutilth\u201D, allen daartoe woonstkeuze gedaan hebbende te 1000 Brussel, Terhulpsesteenweg 120, evenals aan hun bedienden, aangestelden en lasthebbers, allen individueel bevoegd, met mogelijkheid tot indeplaatsstelling, teneinde het aandelenregister, het register van winstbewijzen en het register van de verschillende categorie\u00EBn van inschrijvingsrechten bij te werken.",
"holder_kbo": null,
"holder_name": "NautaDutilth",
"scope_categories": [
"share_register_update",
"warrant_register_update",
"rights_register_update",
"KBO_filing",
"court_filing",
"publication_formalities"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}31-07-2024 5 directors appointed
- GUPTA Varun — Bestuurder
- GODDEERIS Caroline — Bestuurder
- VAN WEZEL Edward — Bestuurder
- VANGINDERTAEL Jeroen — Bestuurder
- VERVERKEN Cedric — Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "GUPTA Varun",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Wellington Partners Life Sciences V GmbH \u0026 Co. KG",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De vergadering beslist om volgende personen te (her)benoemen tot bestuurders, voor een duurtijd van zes (6) jaar en dit met onmiddellijke ingang: (i) Wellington Partners Life Sciences V GmbH \u0026 Co. KG, een vennootschap naar Duits recht, met statutaire zetel te M\u00FCnchen en met vestigingsadres te T\u00FCrken"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "GODDEERIS Caroline",
"address": null,
"birth_date": null
},
"evidence_quote": "De vergadering beslist om volgende personen te (her)benoemen tot bestuurders, voor een duurtijd van zes (6) jaar en dit met onmiddellijke ingang: ... (ii) mevrouw GODDEERIS Caroline, geboren te Genk op 7 september 1980, wonende te Chrisantenlaan 20, 3550 Heusden-Zolder, Belgi\u00EB;"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "VAN WEZEL Edward",
"address": null,
"birth_date": null
},
"evidence_quote": "De vergadering beslist om volgende personen te (her)benoemen tot bestuurders, voor een duurtijd van zes (6) jaar en dit met onmiddellijke ingang: ... (iii) de heer VAN WEZEL Edward, geboren te De Bilt op 5 juli 1964, wonende te Utrechtseweg 31D, 3811 NA Amersfoort, Nederland;"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "VANGINDERTAEL Jeroen",
"address": null,
"birth_date": null
},
"evidence_quote": "De vergadering beslist om volgende personen te (her)benoemen tot bestuurders, voor een duurtijd van zes (6) jaar en dit met onmiddellijke ingang: ... (iv) de heer VANGINDERTAEL Jeroen, geboren te Leuven op 23 november 1986, en voor de uitoefening van dit mandaat woonplaats kiezend op het adres van w"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "VERVERKEN Cedric",
"address": null,
"birth_date": null
},
"evidence_quote": "De vergadering beslist om volgende personen te (her)benoemen tot bestuurders, voor een duurtijd van zes (6) jaar en dit met onmiddellijke ingang: ... (v) de heer VERVERKEN Cedric, geboren te Leuven op 28 oktober 1978, wonende te Zwijnaardsesteenweg 79, 9820 Merelbeke, Belgi\u00EB;"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "CONFO THERAPEUTICS, AFGEKORT : CONFO",
"legal_form": "NV"
}
}31-07-2024 6 directors appointed, 1 resigning
- Wellington Partners Life Sciences V GmbH & Co. KG — Investeerder bestuurder
- Caroline Goddeeris — Investeerder bestuurder
- Edward van Wezel — Investeerder bestuurder
- Jeroen Vangindertael — Investeerder bestuurder
- Cedric Ververken — Investeerder bestuurder
- Robert Scott — Onafhankelijke bestuurder
- ParticipatieMaatschappij Vlaanderen NV — Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "ParticipatieMaatschappij Vlaanderen NV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Investeerder Bestuurder",
"person": {
"rrn": null,
"name": "Wellington Partners Life Sciences V GmbH \u0026 Co. KG",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Investeerder Bestuurder",
"person": {
"rrn": null,
"name": "Caroline Goddeeris",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Investeerder Bestuurder",
"person": {
"rrn": null,
"name": "Edward van Wezel",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Investeerder Bestuurder",
"person": {
"rrn": null,
"name": "Jeroen Vangindertael",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Investeerder Bestuurder",
"person": {
"rrn": null,
"name": "Cedric Ververken",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Onafhankelijke Bestuurder",
"person": {
"rrn": null,
"name": "Robert Scott",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "Confo Therapeutics"
}
}31-07-2024 Capital increase of €11,423,615.45 to €39,926,607.45
- €28.502.992 → €39.926.607,45
- 2 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 11423615.45,
"currency": "EUR",
"after_eur": 39926607.45,
"delta_eur": 11423615.45,
"before_eur": 28502992.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-07-18",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 11.423.615,45 EUR, om het van 28.502.992,00 EUR te brengen op 39.926.607,45 EUR, door middel van inbrengen in natura",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 10862694.15,
"currency": "EUR",
"after_eur": 50789301.6,
"delta_eur": 10862694.15,
"before_eur": 39926607.45,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-07-18",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 10.862.694,15 EUR, om het van 39.926.607,45 EUR te brengen op 50.789.301,60 EUR, door middel van inbrengen in geld",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "CONFO THERAPEUTICS, AFGEKORT : CONFO",
"legal_form": "NV"
}
}31-07-2024 Articles of association amended — translation of the articles, coordination of the articles and full restatement of the articles
Technical details
{
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-07-31",
"filing_date": "2024-07-29",
"act_kind_objet": "KAPITAAL, AANDELEN, ONTSLAGEN, BENOEMINGEN, STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN)"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-07-18",
"unanimous": null
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"full_restatement",
"object_change",
"share_class_creation",
"board_authorized_capital",
"governance_restructure",
"liquidation_preference_introduction",
"seat_region_change"
],
"scope": "full_restatement",
"trigger": "wvv_adaptation",
"language_after": "nl",
"language_before": "nl"
},
"bedrijfsrevisor": {
"firm_kbo": null,
"firm_name": "BDO Bedrijfsrevisoren",
"ibr_number": null,
"individual_name": "CATRY Veerle"
},
"subject_company": {
"kbo": "0632.474.939",
"name_full_after": "Confo Therapeutics",
"legal_form_after": "Naamloze vennootschap",
"name_full_before": "Confo Therapeutics",
"current_zetel_raw": "Technologiepark-Zwijnaarde 30, 9052 Gent",
"legal_form_before": "Naamloze vennootschap"
},
"special_mandates": [
{
"holder_kbo": null,
"holder_name": "NautaDutilth",
"scope_categories": [
"kbo"
],
"with_substitution": true
}
],
"articles_modified": [
{
"summary": "Referentie naar de commissarisverslaggeving.",
"new_text": null,
"change_kind": "amended",
"article_title": null,
"article_number": "7:155"
},
{
"summary": "Referentie naar de commissarisverslaggeving.",
"new_text": null,
"change_kind": "amended",
"article_title": null,
"article_number": "7:179"
},
{
"summary": "Referentie naar de commissarisverslaggeving.",
"new_text": null,
"change_kind": "amended",
"article_title": null,
"article_number": "7:180"
},
{
"summary": "Referentie naar de commissarisverslaggeving.",
"new_text": null,
"change_kind": "amended",
"article_title": null,
"article_number": "7:197"
}
],
"governance_change": {
"organ_kind_after": "college",
"organ_kind_before": "college",
"admin_delegated_added": [
{
"name": "CEO",
"excluded_powers": []
},
{
"name": "Onafhankelijke Bestuurder",
"excluded_powers": []
}
],
"representation_rule_after": "twee_gezamenlijk",
"co_signature_threshold_eur": null,
"representation_rule_before": "twee_gezamenlijk"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim CARNEWAL",
"org_rep_person_name": null
},
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"negentien volmachten",
"het verslag van de raad van bestuur opgesteld in toepassing van artikelen 7:155, 7:179, \u00A71, 7:180 en 7:197, \u00A71 van het Wetboek van vennootschappen en verenigingen",
"de geco\u00F6rdineerde tekst van de statuten"
],
"shareholder_rights": {
"quorum_rules_changed": false,
"liquidation_preference_text": "In geval van een Vereffeningsgebeurtenis, indien de uitbetaling van de Netto Opbrengsten pro rata het bezit van de Aandelen en Winstbewijzen (ten opzichte van het totale aantal Aandelen en Winstbewijzen) tot gevolg zou hebben dat de houders van de betrokken Aandelen en Winstbewijzen een bedrag per Aandeel of Winstbewijs zouden ontvangen dat (vermeerderd met het totaalbedrag van eventuele andere uitkeringen die door de Vennootschap zijn betaald met betrekking tot het desbetreffende Aandeel of Winstbewijs voorafgaand aan de uitkering van de Netto Opbrengsten als onderdeel van de desbetreffende Vereffeningsgebeurtenis, indien van toepassing) gelijk aan of groter is dan het Bevoorrechte Bedrag, zullen de Netto Opbrengsten worden verdeeld pro rata het bezit van de Aandelen en Winstbewijzen in de Vennootschap (ten opzichte van het totale aantal Aandelen en Winstbewijzen), met uitzondering van hetgeen is bepaald in artikelen 42.4 tot 42.6, en dit rekening houdend met het percentage van hun Aandelen en/of Winstbewijzen dat daadwerkelijk is volstort bij het zich voordoen van de Vereffeningsgebeurtenis.",
"voorkeurrecht_rules_changed": false,
"aandelenoverdracht_restrictions_changed": false
},
"voorwerp_change_summary": "De vennootschap heeft tot voorwerp het exploiteren van biologische, chemische of andere producten, processen en technologie\u00EBn in de life sciences sector, het wereldwijd verspreiden en verkopen van producten, het oprichten en deelnemen in vennootschappen, het financieren van ondernemingen, het verstrekken van adviezen, het verstrekken van garanties, het verkrijgen en beheren van vermogenswaarden, het verhandelen van valuta en effecten, het verkrijgen van octrooien en merkrechten, en het verrichte",
"capital_structure_change": {
"operations": [
"share_class_creation",
"capital_increase_cash",
"capital_increase_kind",
"wvv_capital_release",
"share_cancellation",
"share_class_merge"
],
"split_ratio": null,
"shares_after": 12789428,
"shares_before": null,
"capital_after_eur": 50789301.6,
"capital_before_eur": 28502992.0,
"share_classes_after": [
{
"count": 500000,
"label": "Soort A Aandelen",
"rights_summary": null,
"voting_per_share": 1.0
},
{
"count": 6675748,
"label": "Soort B Aandelen",
"rights_summary": null,
"voting_per_share": 1.0
},
{
"count": 1675000,
"label": "Soort B1 aandelen",
"rights_summary": null,
"voting_per_share": 1.0
},
{
"count": 5000748,
"label": "Soort B2 aandelen",
"rights_summary": null,
"voting_per_share": 1.0
},
{
"count": 5613680,
"label": "Soort C Aandelen",
"rights_summary": null,
"voting_per_share": 1.0
}
]
},
"coordinated_text_lineage": null
}31-07-2024 Publication in the Belgian Official Gazette — Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-07-31",
"filing_date": "2024-07-29",
"act_kind_objet": "Technologiepark-Zwijnaarde 30"
},
"decision": {
"body": "enig_aandeelhouder_schriftelijk",
"act_date": "2024-07-18",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0632.474.939",
"name": "Confo Therapeutics",
"role": "other",
"address": "Technologiepark-Zwijnaarde 30 9052 Gent",
"is_foreign": false,
"legal_form": "Naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": null,
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "Confo Therapeutics",
"legal_form": "Naamloze vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim CARNEWAL",
"org_rep_person_name": null
},
"summary_narrative": "De akte van een bijzondere algemene vergadering van Confo Therapeutics, vastgesteld op 18 juli 2024, regelt de uitoefening van inschrijvingsrechten. Hierbij wordt de tekst van artikel 13 bis van de statuten vervangen en worden aan de bestuurders alle bevoegdheden verleend om de inschrijvingsrechten uit te schrijven en de winstbewijzen in te schrijven.",
"co_filed_documents": [
"een uitgifte van de akte",
"\u00E9\u00E9n volmacht",
"de geco\u00F6rdineerde tekst van de statuten"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "statutes"
}31-07-2024 Capital increase of €10,862,694.15 to €50,789,301.60
- €39.926.607,45 → €50.789.301,60
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 50789301.6,
"delta_eur": 10862694.149999999,
"before_eur": 39926607.45,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "Confo Therapeutics"
}
}31-07-2024 Publication in the Belgian Official Gazette — Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-07-31",
"filing_date": "2024-07-29",
"act_kind_objet": "Technologiepark-Zwijnaarde 30"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2024-07-18",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0632.474.939",
"name": "Confo Therapeutics",
"role": "other",
"address": "Technologiepark-Zwijnaarde 30, 9052 Gent",
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"173,1\u00B0 bis"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "De overdracht betreft de uitgifte van winstbewijzen (\u2018Winstbewijzen\u2019) in het kader van de uitoefening van inschrijvingsrechten. Er wordt geen overdracht van het volledige of gedeelte van het patrimoine van de vennootschap uitgevoerd.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "Confo Therapeutics",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim CARNEWAL",
"org_rep_person_name": null
},
"summary_narrative": "Op 18 juli 2024 heeft de algemene vergadering van Confo Therapeutics (NV) besloten tot wijziging van artikel 13 bis, eerste punt, van de statuten, met name in verband met de uitgifte van winstbewijzen in het kader van de uitoefening van inschrijvingsrechten. De vergadering verleent ook de nodige bevoegdheden aan de bestuurders om de uitgifte van winstbewijzen en de registratie daarvan in het winstbewijzenregister uit te voeren.",
"co_filed_documents": [
"uitgifte van de akte",
"\u00E9\u00E9n volmacht",
"de geco\u00F6rdineerde tekst van de statuten"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "statutes"
}11-06-2024 2 directors appointed, 1 resigning
- Varun Gupta — Bestuurder
- Cedric Ververken — Gedelegeerd bestuurder
- Karl Nägler — Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Karl N\u00E4gler",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Wellington Partners Life Sciences V GmbH \u0026 Co. KG",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-03-08",
"evidence_quote": "De raad van bestuur heeft kennisgenomen van de beslissing van Wellington Partners Life Sciences V GmbH \u0026 Co. KG, een vennootschap naar Duits recht, ... om de heer Karl N\u00E4gler, als vaste vertegenwoordiger voor de uitoefening van haar bestuursmandaat in de Vennootschap, te vervangen door de heer Varun"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Varun Gupta",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Wellington Partners Life Sciences V GmbH \u0026 Co. KG",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-03-08",
"evidence_quote": "De raad van bestuur heeft kennisgenomen van de beslissing van Wellington Partners Life Sciences V GmbH \u0026 Co. KG, een vennootschap naar Duits recht, ... om de heer Karl N\u00E4gler, als vaste vertegenwoordiger voor de uitoefening van haar bestuursmandaat in de Vennootschap, te vervangen door de heer Varun"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Cedric Ververken",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "CVBioConsulting BV",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Daarnaast werd het dagelijks bestuur van de Vennootschap, in overeenstemming met artikel 22 van de statuten, opgedragen aan CVBioConsulting BV, vast vertegenwoordigd door Cedric Ververken."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "CONFO THERAPEUTICS, AFGEKORT : CONFO",
"legal_form": "NV"
}
}11-06-2024 1 director appointed, 1 resigning
- Varun Gupta — Vaste vertegenwoordiger
- Karl Nägler — Vaste vertegenwoordiger
Technical details
{
"events": [
{
"kind": "director_out",
"role": "Vaste Vertegenwoordiger",
"person": {
"rrn": null,
"name": "Karl N\u00E4gler",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Vaste Vertegenwoordiger",
"person": {
"rrn": null,
"name": "Varun Gupta",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "CONFO THERAPEUTICS"
}
}11-06-2024 Cedric Ververken appointed as daily management
- Cedric Ververken — Dagelijks bestuur
Technical details
{
"events": [
{
"kind": "rep_rotation",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Varun Gupta",
"address": "Einsteinstra\u00DFe 123, 81675 M\u00FCnchen (Duitsland)",
"birth_date": "1986-08-16",
"profession": null,
"birth_place": "Delhi"
},
"reason": null,
"subkind": "successor_conditional",
"via_org": {
"kbo": null,
"name": "Wellington Partners Life Sciences V GmbH \u0026 Co. KG",
"address": "T\u00FCrkenstra\u00DFe 5, 80333, M\u00FCnchen (Duitsland)",
"country": "DE",
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": "2024-03-08",
"evidence_quote": "om de heer Karl N\u00E4gler, als vaste vertegenwoordiger voor de uitoefening van haar bestuursmandaat in de Vennootschap, te vervangen door de heer Varun Gupta",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": "Varun Gupta",
"rep_rotation_old_rep": "Karl N\u00E4gler",
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Bart De Taeye",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "ParticipatieMaatschappij Vlaanderen NV",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": "Investeerder Bestuurder",
"person": {
"rrn": null,
"name": "Varun Gupta",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Wellington Partners Life Sciences V GmbH \u0026 Co. KG",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": "Investeerder Bestuurder",
"person": {
"rrn": null,
"name": "Edward van Wezel",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": "Investeerder Bestuurder",
"person": {
"rrn": null,
"name": "Caroline Goddeeris",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": "Onafhankelijke Bestuurder",
"person": {
"rrn": null,
"name": "Robert Scott",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": "Onafhankelijke Bestuurder",
"person": {
"rrn": null,
"name": "Dieter Weinand",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": null,
"person": {
"rrn": null,
"name": "Cedric Ververken",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Cedric Ververken",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "CVBioConsulting BV",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "het dagelijks bestuur van de Vennootschap, in overeenstemming met artikel 22 van de statuten, opgedragen aan CVBioConsulting BV, vast vertegenwoordigd door Cedric Ververken.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-06-11",
"filing_date": "2024-05-31",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "raad_van_bestuur",
"date": "2024-05-23",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0632.474.939",
"name_full": "CONFO THERAPEUTICS",
"legal_form": "NAAMLOZE VENNOOTSCHA\u0420"
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}29-03-2024 Publication in the Belgian Official Gazette — Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-03-29",
"filing_date": "2024-03-27",
"act_kind_objet": "DIVERSEN"
},
"decision": {
"body": "enig_aandeelhouder_schriftelijk",
"act_date": "2024-03-22",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0632.474.939",
"name": "Confo Therapeutics",
"role": "other",
"address": "Technologiepark-Zwijnaarde 30, 9052 Gent",
"is_foreign": false,
"legal_form": "Naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": null,
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0632.474.939",
"name_full": "Confo Therapeutics",
"legal_form": "Naamloze vennootschap"
},
"detected_kind_raw": "material_correction",
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim CARNEWAL",
"org_rep_person_name": null
},
"summary_narrative": "De notaris stelt vast dat 500 inschrijvingsrechten zijn uitgegeven, wat recht geeft op 500 winstbewijzen. Op deze winstbewijzen is in totaal 2.000,00 EUR ingeschreven. De tekst van artikel 13 bis, eerste punt van de statuten wordt vervangen.",
"co_filed_documents": [
"een uitgifte van de akte",
"\u00E9\u00E9n volmacht",
"de geco\u00F6rdineerde tekst van de statuten"
],
"detected_real_type": "other",
"referenced_correction": {
"prior_pub_date": null,
"what_corrected": "publication",
"prior_pub_number": "24383069"
},
"should_reroute_to_category": "statutes"
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Confo Therapeutics |
| AbbreviationNL | Confo |